Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Lianxia Xiaopi Granules for Postprandial Distress Syndrome (cold-heat complex pattern) – Phase III
CTR20244021Phase 3Active
- Sponsor
- Tasly Pharmaceutical Group Co., Ltd.
- Start
- Mar 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of Lianxia Xiaopi Granules in functional dyspepsia (FD), sponsored by Tasly Pharmaceutical Group Co., Ltd.. Started Mar 2025; status: active.
02
Drugs
Lianxia Xiaopi Granules
03
Conditions
functional dyspepsia (FD)
Beyond the preview
Go deeper on CTR20244021.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20244021.